Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-2-21
pubmed:abstractText
This study compared the efficacy and tolerability of the combination of fluticasone propionate (FP) and salmeterol (SAL) delivered via a single hydrofluoroalkane (HFA) 134a metered-dose inhaler (MDI) with those of its 2 components alone delivered via a chlorofluorocarbon (CFC) MDI and placebo (PLA) delivered via HFA MDI in adolescent and adult patients with persistent asthma that was not controlled by medium doses (equivalent to FP 440-660 microg/d) of inhaled corticosteroids (ICSs).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0149-2918
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-85
pubmed:meshHeading
pubmed-meshheading:16490581-Adolescent, pubmed-meshheading:16490581-Adult, pubmed-meshheading:16490581-Aerosol Propellants, pubmed-meshheading:16490581-Aged, pubmed-meshheading:16490581-Aged, 80 and over, pubmed-meshheading:16490581-Albuterol, pubmed-meshheading:16490581-Androstadienes, pubmed-meshheading:16490581-Asthma, pubmed-meshheading:16490581-Bronchodilator Agents, pubmed-meshheading:16490581-Child, pubmed-meshheading:16490581-Double-Blind Method, pubmed-meshheading:16490581-Drug Administration Schedule, pubmed-meshheading:16490581-Female, pubmed-meshheading:16490581-Follow-Up Studies, pubmed-meshheading:16490581-Forced Expiratory Volume, pubmed-meshheading:16490581-Humans, pubmed-meshheading:16490581-Hydrocarbons, Fluorinated, pubmed-meshheading:16490581-Male, pubmed-meshheading:16490581-Metered Dose Inhalers, pubmed-meshheading:16490581-Middle Aged, pubmed-meshheading:16490581-Spirometry, pubmed-meshheading:16490581-Time Factors, pubmed-meshheading:16490581-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
pubmed:affiliation
Asthma and Allergy Associates, Colorado Springs, Colorado 80907, USA. drrnathan@aol.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial